Role of Glucocorticoids in Metabolic Dysfunction-Associated Steatotic Liver Disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Role of Glucocorticoids in Metabolic Dysfunction-Associated Steatotic Liver Disease ; day:8 ; month:3 ; year:2024 ; pages:1-14
Current obesity reports ; (8.3.2024), 1-14
- Creator
-
Polyzos, Stergios A.
Targher, Giovanni
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s13679-024-00556-1
- URN
-
urn:nbn:de:101:1-2405112118495.840582373343
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:46 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Polyzos, Stergios A.
- Targher, Giovanni
- SpringerLink (Online service)
Other Objects (12)
Interplay between YAP/TAZ and metabolic dysfunction-associated steatotic liver disease progression
Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk: a comprehensive review
Effects of semaglutide-loaded lipid nanocapsules on metabolic dysfunction-associated steatotic liver disease
Single‐cell transcriptomics stratifies organoid models of metabolic dysfunction‐associated steatotic liver disease
IFNγ-IL12 axis regulates intercellular crosstalk in metabolic dysfunction-associated steatotic liver disease
Ferroptosis is a targetable detrimental factor in metabolic dysfunction-associated steatotic liver disease
Metabolic dysfunction-associated steatotic liver disease and gallbladder polyp development: an observational study
Risk of binge eating disorder in patients with metabolic dysfunction-associated steatotic liver disease
Advances in management of metabolic dysfunction-associated steatotic liver disease: from mechanisms to therapeutics
The plasma lipidome varies with the severity of metabolic dysfunction-associated steatotic liver disease
A male mouse model for metabolic dysfunction-associated steatotic liver disease and hepatocellular carcinoma
An integrated gene-to-outcome multimodal database for metabolic dysfunction-associated steatotic liver disease
Interplay between YAP/TAZ and metabolic dysfunction-associated steatotic liver disease progression
Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk: a comprehensive review
Effects of semaglutide-loaded lipid nanocapsules on metabolic dysfunction-associated steatotic liver disease
Single‐cell transcriptomics stratifies organoid models of metabolic dysfunction‐associated steatotic liver disease
IFNγ-IL12 axis regulates intercellular crosstalk in metabolic dysfunction-associated steatotic liver disease
Ferroptosis is a targetable detrimental factor in metabolic dysfunction-associated steatotic liver disease
Metabolic dysfunction-associated steatotic liver disease and gallbladder polyp development: an observational study
Risk of binge eating disorder in patients with metabolic dysfunction-associated steatotic liver disease
Advances in management of metabolic dysfunction-associated steatotic liver disease: from mechanisms to therapeutics
The plasma lipidome varies with the severity of metabolic dysfunction-associated steatotic liver disease
A male mouse model for metabolic dysfunction-associated steatotic liver disease and hepatocellular carcinoma
An integrated gene-to-outcome multimodal database for metabolic dysfunction-associated steatotic liver disease
Interplay between YAP/TAZ and metabolic dysfunction-associated steatotic liver disease progression
Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk: a comprehensive review
Effects of semaglutide-loaded lipid nanocapsules on metabolic dysfunction-associated steatotic liver disease
Single‐cell transcriptomics stratifies organoid models of metabolic dysfunction‐associated steatotic liver disease
IFNγ-IL12 axis regulates intercellular crosstalk in metabolic dysfunction-associated steatotic liver disease
Ferroptosis is a targetable detrimental factor in metabolic dysfunction-associated steatotic liver disease
Metabolic dysfunction-associated steatotic liver disease and gallbladder polyp development: an observational study
Risk of binge eating disorder in patients with metabolic dysfunction-associated steatotic liver disease
Advances in management of metabolic dysfunction-associated steatotic liver disease: from mechanisms to therapeutics
The plasma lipidome varies with the severity of metabolic dysfunction-associated steatotic liver disease
A male mouse model for metabolic dysfunction-associated steatotic liver disease and hepatocellular carcinoma